Elanco Animal Health (ELAN) Exchange Rate Effect (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly Exchange Rate Effect came in at -$5.0 million in Q1 2026, down 117.24% year-on-year from $29.0 million in Q1 2025, and down 135.71% quarter-over-quarter from $14.0 million in Q4 2025.
Elanco Animal Health (ELAN) Exchange Rate Effect (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Exchange Rate Effect across 10 years of filings, most recently posting -$5.0 million for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$5.0 million, down 117.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $37.0 million (up 186.05% YoY), and the FY2025 annual result was $71.0 million, up 178.02% from the prior year.
- Exchange Rate Effect came in at -$5.0 million for Q1 2026 at Elanco Animal Health, down from $14.0 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $32.0 million in Q4 2022 to a low of -$77.0 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$3.0 million (2023), against an average of -$3.4 million.
- Across the five-year window, Exchange Rate Effect sank 1800.0% in 2024 and jumped 1000.0% in 2025, its largest moves.
- Elanco Animal Health's Exchange Rate Effect stood at $32.0 million in 2022, then slumped by 109.38% to -$3.0 million in 2023, then sank by 2466.67% to -$77.0 million in 2024, then soared by 118.18% to $14.0 million in 2025, then slumped by 135.71% to -$5.0 million in 2026.
- The last three Exchange Rate Effect figures came in at -$5.0 million (Q1 2026), $14.0 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -22,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -2.38 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.00 Mn |
| Mar 31, 2026 | -5.00 Mn |
| Dec 31, 2025 | 14.00 Mn |
| Dec 31, 2025 | 14.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 27.00 Mn |
| Jun 30, 2025 | 27.00 Mn |
| Mar 31, 2025 | 29.00 Mn |
| Mar 31, 2025 | 29.00 Mn |
| Dec 31, 2024 | -77.00 Mn |
| Dec 31, 2024 | -77.00 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | -3.00 Mn |
| Jun 30, 2024 | -3.00 Mn |
| Mar 31, 2024 | -19.00 Mn |
| Mar 31, 2024 | -19.00 Mn |
| Sep 30, 2023 | -3.00 Mn |
| Sep 30, 2023 | -3.00 Mn |